{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:10:57Z","timestamp":1767802257695,"version":"3.49.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-01048-1","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:26:19Z","timestamp":1764786379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Condensation of fluconazole and zinc undecylanate particles using low-pressure RF plasma: a novel drug combination approach"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4320-3567","authenticated-orcid":false,"given":"Nam\u0131k","family":"Bilici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2669-021X","authenticated-orcid":false,"given":"Ferhat","family":"Bozduman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"1048_CR1","doi-asserted-by":"publisher","first-page":"984","DOI":"10.2165\/00003495-199549060-00009","volume":"49","author":"CM Perry","year":"1995","unstructured":"Perry CM, Whittington R, McTavish D. Fluconazole. An update of its antimicrobial activity, pharmacokinetic properties, and therapeutic use in vaginal candidiasis. Drugs. 1995;49:984\u20131006. https:\/\/doi.org\/10.2165\/00003495-199549060-00009.","journal-title":"Drugs"},{"key":"1048_CR2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1159\/000007136","volume":"44","author":"H Mikamo","year":"1998","unstructured":"Mikamo H, Kawazoe K, Sato Y, Hayasaki Y, Tamaya T. Comparative study on the effectiveness of antifungal agents in different regimens against vaginal candidiasis. Chemotherapy. 1998;44:364\u201368. https:\/\/doi.org\/10.1159\/000007136.","journal-title":"Chemotherapy"},{"key":"1048_CR3","first-page":"20","volume":"43","author":"R Vacheva-Dobrevski","year":"2004","unstructured":"Vacheva-Dobrevski R, Kovachev S, Nacheva A, Stoev S, Vasilev N. Comparative study of itraconazole and fluconazole therapy in vaginal candidosis. Akush Ginekol (Sofiia). 2004;43:20\u201323.","journal-title":"Akush Ginekol (Sofiia)"},{"key":"1048_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1742-1241.1995.tb09895.x","volume":"49","author":"PD Woolley","year":"1995","unstructured":"Woolley PD, Higgins SP. Comparison of clotrimazole, fluconazole and itraconazole in vaginal candidiasis. Br J Clin Pract. 1995;49:65\u201366.","journal-title":"Br J Clin Pract"},{"key":"1048_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4103\/2230-973X.177826","volume":"6","author":"K Pathak","year":"2016","unstructured":"Pathak K, Sharma V, Akhtar N, Rastogi P. Localization of fluconazole in oral cavity by preferential coating of buccoadhesive tablet for treatment of oral thrush. Int J Pharm Investig. 2016;6:106\u201315. https:\/\/doi.org\/10.4103\/2230-973X.177826.","journal-title":"Int J Pharm Investig"},{"key":"1048_CR6","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox C, Wilson M, Klinger CM, Franklin M, Oler E, Wilson A, et al. DrugBank 6.0: the DrugBank knowledgebase for 2024. Nucleic Acids Res. 2024;52:D1265\u201375.","journal-title":"Nucleic Acids Res"},{"key":"1048_CR7","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.3390\/molecules23051122","volume":"23","author":"S Guo","year":"2018","unstructured":"Guo S, Yang W, Zhao M, Tian R, Zhang B, Qi Y. In vitro anticandidal activity and mechanism of a polyoxovanadate functionalized by Zn-fluconazole complexes. Molecules. 2018;23:1122. https:\/\/doi.org\/10.3390\/molecules23051122.","journal-title":"Molecules"},{"key":"1048_CR8","doi-asserted-by":"publisher","first-page":"e202301960","DOI":"10.1002\/cbdv.202301960","volume":"21","author":"JW Almeida-Bezerra","year":"2024","unstructured":"Almeida-Bezerra JW, Pereira da Cruz R, Bezerra da Silva V, Da Silva Neto JX, Alves Lopes de Souza L, de Oliveira Bezerra de Sousa D, et al. Exploring the fluconazole-resistance modifying activity and potential mechanism of action of fixed oil from Caryocar coriaceum Wittm. (Caryocaraceae) against Candida species. Chem Biodivers. 2024;21:e202301960.","journal-title":"Chem Biodivers"},{"key":"1048_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13054-015-0758-3","volume":"19","author":"MG Sinnollareddy","year":"2015","unstructured":"Sinnollareddy MG, Roberts JA, Lipman J, Akova M, Bassetti M, De Waele JJ, et al. Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study. Crit Care. 2015;19:33.","journal-title":"Crit Care"},{"key":"1048_CR10","doi-asserted-by":"publisher","unstructured":"Li Z, Tan X, Yarmolenko MA, K A, Wang A, Liu X, et al. Deposition of ethyl cellulose-based drug-carrying coating by low-energy electron beam dispersion and its antifungal properties. Vacuum. 2025;236:114136. doi:https:\/\/doi.org\/10.1016\/j.vacuum.2025.114136","DOI":"10.1016\/j.vacuum.2025.114136"},{"issue":"Suppl 2","key":"1048_CR11","first-page":"30","volume":"42","author":"V Mazne\u012dkova","year":"2003","unstructured":"Mazne\u012dkova V.[Vaginal candidiasis\u2013treatment protocols using miconazole and fluconazole]. Akush Ginekol (Sofiia). 2003;42(Suppl 2):30\u201334.","journal-title":"Akush Ginekol (Sofiia)"},{"key":"1048_CR12","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.22034\/APJCP.2018.19.6.1543","volume":"19","author":"M Pourghasemian","year":"2018","unstructured":"Pourghasemian M, Mehdizadeh M, Hajfathali A, Habibzadeh A, Hosseini MH. The role of fluconazole prophylaxis regimen and the regimes chosen by the patient\u2019s risk of fungal infection in reducing the infection rate after bone marrow transplantation. Asian Pac J Cancer Prev. 2018;19:1543\u201346. https:\/\/doi.org\/10.22034\/APJCP.2018.19.6.1543.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1048_CR13","doi-asserted-by":"publisher","first-page":"e202402505","DOI":"10.1002\/slct.202402505","volume":"10","author":"T Ringu","year":"2025","unstructured":"Ringu T, Das A, Ali MS, Ghosh S, Pramanik N. Fluconazole functionalized copper oxide\u2014chitosan nanocomposite for bioengineering applications against human breast cancer therapies. ChemistrySelect. 2025;10:e202402505. https:\/\/doi.org\/10.1002\/slct.202402505.","journal-title":"ChemistrySelect"},{"key":"1048_CR14","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/vnl.22098","volume":"30","author":"A Das","year":"2024","unstructured":"Das A, Ringu T, Ghosh S, Pramanik N. High efficacy fluconazole loaded ZnO -poly (vinyl alcohol) nanocomposite: interpretive breakpoints for biological applications. J Vinyl Addit Technol. 2024;30:969\u201382. https:\/\/doi.org\/10.1002\/vnl.22098.","journal-title":"J Vinyl Addit Technol"},{"key":"1048_CR15","doi-asserted-by":"publisher","unstructured":"\u062a\u06cc\u0645\u0648\u0631\u06cc \u0633, \u0627\u0646\u0635\u0627\u0631\u06cc \u062d, \u0634\u0641\u06cc\u0639\u06cc \u0641, \u0648\u0631\u0634\u0648\u0633\u0627\u0632 \u0698. Preparation and in-vitro evaluation of inhalable powder containing fluconazole nanoparticles for the treatment of pulmonary fungal infections. J Isfahan Med Sch. 2023;41. https:\/\/doi.org\/10.48305\/jims.v41.i728.0604.","DOI":"10.48305\/jims.v41.i728.0604"},{"key":"1048_CR16","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.pharma.2024.04.001","volume":"82","author":"A Sapra","year":"2024","unstructured":"Sapra A, Hm H, Amin SM, Kelsi SFA, Nur S, Permana AD. Development of mucoadhesive microspheres for intranasal delivery of fluconazole as an alternative treatment of cryptococcal meningitis infection in patients with acquired immunodeficiency. Ann Pharm Fr. 2024;82:813\u201321. https:\/\/doi.org\/10.1016\/j.pharma.2024.04.001.","journal-title":"Ann Pharm Fr"},{"key":"1048_CR17","doi-asserted-by":"publisher","first-page":"102104","DOI":"10.1016\/j.jsps.2024.102104","volume":"32","author":"BN Aldosari","year":"2024","unstructured":"Aldosari BN, Ibrahim MA, Alqahtani Y, Aesf AEE. Formulation and evaluation of Fluconazole Nanosuspensions: in vitro characterization and transcorneal permeability studies. Saudi Pharm J. 2024;32:102104. https:\/\/doi.org\/10.1016\/j.jsps.2024.102104.","journal-title":"Saudi Pharm J"},{"key":"1048_CR18","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/pharmaceutics14030641","volume":"14","author":"K Brunet","year":"2022","unstructured":"Brunet K, Martellosio J-P, Tewes F, Marchand S, Rammaert B. Inhaled antifungal agents for treatment and prophylaxis of bronchopulmonary invasive mold infections. Pharmaceutics. 2022;14:641. https:\/\/doi.org\/10.3390\/pharmaceutics14030641.","journal-title":"Pharmaceutics"},{"key":"1048_CR19","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3390\/pharmaceutics12121161","volume":"12","author":"SN Cheng","year":"2020","unstructured":"Cheng SN, Tan ZG, Pandey M, Srichana T, Pichika MR, Gorain B, et al. A critical review on emerging trends in dry powder inhaler formulation for the treatment of pulmonary aspergillosis. Pharmaceutics. 2020;12:1161.","journal-title":"Pharmaceutics"},{"key":"1048_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.15171\/PS.2018.32","volume":"24","author":"H Hamishehkar","year":"2018","unstructured":"Hamishehkar H, Pourtahmaseb M, Babazadeh A, Alipour S. Physicochemical and aerosolization assessment of inhalable spray dried fluconazole powder. Pharm Sci. 2018;24:219\u201326. https:\/\/doi.org\/10.15171\/PS.2018.32.","journal-title":"Pharm Sci"},{"key":"1048_CR21","doi-asserted-by":"publisher","unstructured":"Al-Khafaji Z, Brito S, Bin B-H. Zinc and Zinc transporters in dermatology. Int J Mol Sci. 2022;23:16165. doi:https:\/\/doi.org\/10.3390\/ijms232416165","DOI":"10.3390\/ijms232416165"},{"key":"1048_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/978-1-4612-2614-7_46","volume-title":"Global Dermatology","author":"G Cauwenbergh","year":"1994","unstructured":"Cauwenbergh G. Antifungal therapy. In: Parish LC, Millikan LE, Amer M, Graham-Brown RAC, Klaus SN, Pace JL, editors. Global Dermatology. New York: Springer New York, 1994:317\u201330. DOI:https:\/\/doi.org\/10.1007\/978-1-4612-2614-7_46."},{"key":"1048_CR23","doi-asserted-by":"publisher","first-page":"100054","DOI":"10.1016\/j.jdsct.2024.100054","volume":"1","author":"Z Tang","year":"2024","unstructured":"Tang Z, Du Q. Mechanism of action of preservatives in cosmetics. J Dermatol Sci Cosmet Technol. 2024;1:100054. https:\/\/doi.org\/10.1016\/j.jdsct.2024.100054.","journal-title":"J Dermatol Sci Cosmet Technol"},{"key":"1048_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ph14010024","volume":"14","author":"NL Stevanovi\u0107","year":"2021","unstructured":"Stevanovi\u0107 NL, Aleksic I, Kljun J, Skaro Bogojevic S, Veselinovic A, Nikodinovic-Runic J, et al. Copper(II) and Zinc(II) complexes with the clinically used fluconazole: comparison of antifungal activity and therapeutic potential. Pharmaceuticals. 2021;14:24.","journal-title":"Pharmaceuticals"},{"key":"1048_CR25","doi-asserted-by":"publisher","unstructured":"Roselletti E, Pericolini E, Nore A, Takacs P, Kozma B, Sala A, et al. Zinc prevents vaginal candidiasis by inhibiting expression of an inflammatory fungal protein. Sci Transl Med. 2023:15:eadi3363. doi:https:\/\/doi.org\/10.1126\/scitranslmed.adi3363.","DOI":"10.1126\/scitranslmed.adi3363"},{"key":"1048_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/ics.12463","volume":"40","author":"M Abendrot","year":"2018","unstructured":"Abendrot M, Kalinowska-Lis U. Zinc-containing compounds for personal care applications. Int J Cosmet Sci. 2018;40:319\u201327. https:\/\/doi.org\/10.1111\/ics.12463.","journal-title":"Int J Cosmet Sci"},{"key":"1048_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ph14010024","volume":"14","author":"S NLj","year":"2020","unstructured":"NLj S, Aleksic I, Kljun J, Skaro Bogojevic S, Veselinovic A, Nikodinovic-Runic J, et al. Copper(II) and Zinc(II) complexes with the clinically used fluconazole: comparison of antifungal activity and therapeutic potential. Pharmaceuticals. 2020;14:24.","journal-title":"Pharmaceuticals"},{"key":"1048_CR28","doi-asserted-by":"publisher","first-page":"e70075","DOI":"10.1111\/exd.70075","volume":"34","author":"A Mayfosh","year":"2025","unstructured":"Mayfosh A, Rau T. A novel ammonium carboxylate salt of undecylenic acid for the topical treatment of gram-positive and antibiotic-resistant skin infections. Exp Dermatol. 2025;34:e70075. https:\/\/doi.org\/10.1111\/exd.70075.","journal-title":"Exp Dermatol"},{"key":"1048_CR29","doi-asserted-by":"publisher","first-page":"106136","DOI":"10.1016\/j.antiviral.2025.106136","volume":"237","author":"EA Monson","year":"2025","unstructured":"Monson EA, Lloyd MG, Johnson RI, Caracciolo K, Whan J, Rau TF, et al. GS-1 blocks entry of herpes viruses and more broadly inhibits enveloped viruses. Antiviral Res. 2025;237:106136.","journal-title":"Antiviral Res"},{"key":"1048_CR30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ijantimicag.2013.12.009","volume":"43","author":"S Liu","year":"2014","unstructured":"Liu S, Hou Y, Chen X, Gao Y, Li H, Sun S. Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery. Int J Antimicrob Agents. 2014;43:395\u2013402. https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.12.009.","journal-title":"Int J Antimicrob Agents"},{"key":"1048_CR31","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3390\/jof7090727","volume":"7","author":"L Brescini","year":"2021","unstructured":"Brescini L, Fioriti S, Morroni G, Barchiesi F. Antifungal combinations in dermatophytes. J Fungi. 2021;7:727. https:\/\/doi.org\/10.3390\/jof7090727.","journal-title":"J Fungi"},{"key":"1048_CR32","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/cvde.200606554","volume":"13","author":"M Camero","year":"2007","unstructured":"Camero M, Gordillo-V\u00e1zquez FJ, G\u00f3mez-Aleixandre C. Low-pressure PECVD of nanoparticles in carbon thin films from Ar\/H2\/C2H2 plasmas: synthesis of films and analysis of the electron energy distribution function. Chem Vap Depos. 2007;13:326\u201334. https:\/\/doi.org\/10.1002\/cvde.200606554.","journal-title":"Chem Vap Depos"},{"key":"1048_CR33","doi-asserted-by":"publisher","first-page":"012016","DOI":"10.1088\/1742-6596\/257\/1\/012016","volume":"257","author":"YA Lebedev","year":"2010","unstructured":"Lebedev YA. Microwave discharges: generation and diagnostics. J Phys Conf Ser. 2010;257:012016. https:\/\/doi.org\/10.1088\/1742-6596\/257\/1\/012016.","journal-title":"J Phys Conf Ser"},{"key":"1048_CR34","doi-asserted-by":"publisher","first-page":"113862","DOI":"10.1016\/j.cattod.2022.08.004","volume":"423","author":"A Serrano-Lotina","year":"2023","unstructured":"Serrano-Lotina A, Portela R, Baeza P, Alcolea-Rodriguez V, Villarroel M, \u00c1vila P. Zeta potential as a tool for functional materials development. Catal Today. 2023;423:113862. https:\/\/doi.org\/10.1016\/j.cattod.2022.08.004.","journal-title":"Catal Today"},{"key":"1048_CR35","doi-asserted-by":"publisher","first-page":"100491","DOI":"10.1016\/j.clinsp.2024.100491","volume":"79","author":"VK Matsuno","year":"2024","unstructured":"Matsuno VK, Campos EVD, Silva Junior EMD, Silva Junior JMD, Gomez DDS, SRCJ S. Changes in fluconazole pharmacokinetics can impact on antifungal effectiveness in critically ill burn patients: a Pharmacokinetic-Pharmacodynamic (PK\/PD) approach. Clinics. 2024;79:100491. https:\/\/doi.org\/10.1016\/j.clinsp.2024.100491.","journal-title":"Clinics"},{"key":"1048_CR36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12247-018-9335-z","volume":"14","author":"AAH Abdellatif","year":"2019","unstructured":"Abdellatif AAH, El-Telbany DFA, Zayed G, Al-Sawahli MM. Hydrogel containing PEG-coated fluconazole nanoparticles with enhanced solubility and antifungal activity. J Pharm Innov. 2019;14:112\u201322. https:\/\/doi.org\/10.1007\/s12247-018-9335-z.","journal-title":"J Pharm Innov"},{"key":"1048_CR37","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.2147\/IJN.S103762","volume":"11","author":"S Ren\u00e7ber","year":"2016","unstructured":"Ren\u00e7ber S, Karavana SY, Y\u0131lmaz FF, Era\u00e7 B, Nenni M, \u00d6zbal S, et al. Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis. Int J Nanomedicine. 2016;11:2641\u201353.","journal-title":"Int J Nanomedicine"},{"key":"1048_CR38","doi-asserted-by":"publisher","first-page":"6203","DOI":"10.1021\/acsabm.5c00700","volume":"8","author":"Y Ruan","year":"2025","unstructured":"Ruan Y, Li R, Zheng P, Zhao S, Wang Z, Nie G, et al. AD1 aptamer-engineered fluconazole-loaded PLGA-PEG nanoformulations potentiate antifungal efficacy through biofilm-penetrating targeting against Candida albicans. ACS Appl Bio Mater. 2025;8:6203\u201314.","journal-title":"ACS Appl Bio Mater"},{"key":"1048_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/polym15010209","volume":"15","author":"AM Almehmady","year":"2023","unstructured":"Almehmady AM, El-Say KM, Mubarak MA, Alghamdi HA, Somali NA, Sirwi A, et al. Enhancing the antifungal activity and ophthalmic transport of fluconazole from PEGylated polycaprolactone loaded nanoparticles. Polymers. 2023;15:209.","journal-title":"Polymers"},{"key":"1048_CR40","doi-asserted-by":"publisher","first-page":"25889","DOI":"10.1039\/D0RA00297F","volume":"10","author":"KM Hamad","year":"2020","unstructured":"Hamad KM, Mahmoud NN, Al-Dabash S, Al-Samad LA, Abdallah M, Al-Bakri AG. Fluconazole conjugated-gold nanorods as an antifungal nanomedicine with low cytotoxicity against human dermal fibroblasts. RSC Adv. 2020;10:25889\u201397. https:\/\/doi.org\/10.1039\/D0RA00297F.","journal-title":"RSC Adv"},{"key":"1048_CR41","doi-asserted-by":"publisher","unstructured":"Kolawole OM, Okeke PK. Formulation and Evaluation of boronated 4-arm polyethylene glycol\/polyvinyl pyrrolidone\/methylcellulose-based fluconazole films for the potential treatment of Vaginal Candidiasis. J Drug Deliv Sci Technol. 2025;107:106838. doi:https:\/\/doi.org\/10.1016\/j.jddst.2025.106838","DOI":"10.1016\/j.jddst.2025.106838"},{"key":"1048_CR42","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12886-024-03305-z","volume":"24","author":"Q Guo","year":"2024","unstructured":"Guo Q, Li Z, Cao F. Enhanced systematic delivery of fluconazole-loaded biotin-glutathione functionalized chitosan-g-proline carrier into the infected retinitis treatment. BMC Ophthalmol. 2024;24:48. https:\/\/doi.org\/10.1186\/s12886-024-03305-z.","journal-title":"BMC Ophthalmol"},{"key":"1048_CR43","doi-asserted-by":"publisher","first-page":"e0326940","DOI":"10.1371\/journal.pone.0326940","volume":"20","author":"DM Roberts","year":"2025","unstructured":"Roberts DM, Thomas JE, Salmon JH, Cubeta MA, Stapelmann K, Gilger BC. Cold atmospheric plasma improves antifungal responsiveness of Aspergillus flavus and Fusarium keratoplasticum conidia and mycelia. PLOS ONE. 2025;20:e0326940. https:\/\/doi.org\/10.1371\/journal.pone.0326940.","journal-title":"PLOS ONE"},{"key":"1048_CR44","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3390\/pharmaceutics16101306","volume":"16","author":"A Tikhonov","year":"2024","unstructured":"Tikhonov A, Kachanov A, Yudaeva A, Danilik O, Ponomareva N, Karandashov I, et al. Biomimetic nanoparticles for basic drug delivery. Pharmaceutics. 2024;16:1306.","journal-title":"Pharmaceutics"},{"issue":"Supplement_3","key":"1048_CR45","doi-asserted-by":"publisher","first-page":"S267","DOI":"10.1093\/clinids\/12.Supplement_3.S267","volume":"12","author":"K Richardson","year":"1990","unstructured":"Richardson K, Cooper K, Marriott MS, Tarbit MH, Troke F, Whittle PJ. 1990. Discovery of fluconazole, a novel antifungal agent. Clin Infect Dis. 12(Suppl 3):S267\u201371. https:\/\/doi.org\/10.1093\/clinids\/12.Supplement_3.S267","journal-title":"Clin Infect Dis"},{"key":"1048_CR46","doi-asserted-by":"publisher","first-page":"343","DOI":"10.5414\/CP202460","volume":"54","author":"D Shi","year":"2016","unstructured":"Shi D, Zhao Y, Yan H, Fu H, Shen Y, Lu G, et al. Antifungal effects of undecylenic acid on the biofilm formation of Candida albicans. Int J Clin Pharmacol Ther. 2016;54:343\u201353.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1048_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/709152","volume":"2014","author":"M Gupta","year":"2014","unstructured":"Gupta M, Mahajan VK, Mehta KS, Chauhan PS. Zinc therapy in dermatology: a review. Dermatol Res Pract. 2014;2014:1\u201311. https:\/\/doi.org\/10.1155\/2014\/709152.","journal-title":"Dermatol Res Pract"},{"key":"1048_CR48","doi-asserted-by":"publisher","first-page":"100491","DOI":"10.1016\/j.clinsp.2024.100491","volume":"79","author":"VK Matsuno","year":"2024","unstructured":"Matsuno VK, Campos de EV, Silva Junior da EM, Silva Junior da JM, Gomez de S D, Santos SRCJ. Changes in fluconazole pharmacokinetics can impact on antifungal effectiveness in critically ill burn patients: a Pharmacokinetic-Pharmacodynamic (PK\/PD) approach. Clin Sao Paulo Braz. 2024;79:100491. https:\/\/doi.org\/10.1016\/j.clinsp.2024.100491.","journal-title":"Clin Sao Paulo Braz"},{"key":"1048_CR49","doi-asserted-by":"publisher","first-page":"e00991","DOI":"10.1128\/aac.00991-24","volume":"68","author":"E Matusik","year":"2024","unstructured":"Matusik E, Vassal O, Conrad A, Ferry T, Millet A, Dupont D, et al. Parametric and nonparametric population pharmacokinetic analysis of fluconazole in critically ill patients and dosing simulations for Candida infections. Antimicrob Agents Chemother. 2024;68:e00991\u201324.","journal-title":"Antimicrob Agents Chemother"},{"key":"1048_CR50","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ejps.2016.05.022","volume":"92","author":"JRA Santos","year":"2016","unstructured":"Santos JRA, C\u00e9sar IC, Costa MC, Ribeiro NQ, Holanda RA, Ramos LH, et al. Pharmacokinetics\/pharmacodynamic correlations of fluconazole in murine model of cryptococcosis. Eur J Pharm Sci. 2016;92:235\u201343.","journal-title":"Eur J Pharm Sci"},{"issue":"2_suppl","key":"1048_CR51","doi-asserted-by":"publisher","first-page":"5S","DOI":"10.1177\/10915818241227124","volume":"43","author":"LN Scott","year":"2024","unstructured":"Scott LN, Fiume M, Zhu J, Bergfeld WF, Belsito DV, Hill RA, et al. Safety assessment of zinc salts as used in cosmetics. Int J Toxicol. 2024;43(2_suppl):5S\u201369S. doi:https:\/\/doi.org\/10.1177\/10915818241227124.","journal-title":"Int J Toxicol"},{"key":"1048_CR52","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1080\/09546634.2022.2062282","volume":"33","author":"T Searle","year":"2022","unstructured":"Searle T, Ali FR, Al-Niaimi F. Zinc in dermatology. J Dermatol Treat. 2022;33:2455\u201358. https:\/\/doi.org\/10.1080\/09546634.2022.2062282.","journal-title":"J Dermatol Treat"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01048-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-01048-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01048-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T13:42:55Z","timestamp":1767793375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-025-01048-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1048"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-01048-1","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"3 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"No humans or animals were used in this study. Furthermore, care was taken to comply with other necessary ethical guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that there is no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"6"}}